BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NM, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, Mcnitt S, Olshansky B, Shoda M, Wilber D, Zareba W. Reduction in Inappropriate Therapy and Mortality through ICD Programming. N Engl J Med 2012;367:2275-83. [DOI: 10.1056/nejmoa1211107] [Cited by in Crossref: 900] [Cited by in F6Publishing: 116] [Article Influence: 100.0] [Reference Citation Analysis]
Number Citing Articles
1 Trivedi A, Knight BP. ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy. Arrhythm Electrophysiol Rev 2016;5:188-96. [PMID: 28116084 DOI: 10.15420/aer.2016:30:2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
2 Chinushi M, Saitoh O, Furushima H, Aizawa Y, Noda T, Nitta T, Ohe T, Kurita T. Anti-tachycardia pacing for non-fast and fast ventricular tachycardias in individual Japanese patients: From Nippon-storm study. J Arrhythm 2021;37:1038-45. [PMID: 34386130 DOI: 10.1002/joa3.12572] [Reference Citation Analysis]
3 Callum K, Graune C, Bowman E, Molden E, Leslie SJ. Remote monitoring of implantable defibrillators is associated with fewer inappropriate shocks and reduced time to medical assessment in a remote and rural area. World J Cardiol 2021;13:46-54. [PMID: 33791078 DOI: 10.4330/wjc.v13.i3.46] [Reference Citation Analysis]
4 Aktaş MK, Younis A, Zareba W, Kutyifa V, Klein H, Daubert JP, Estes M, McNitt S, Polonsky B, Goldenberg I. Survival After Implantable Cardioverter-Defibrillator Shocks. J Am Coll Cardiol 2021;77:2453-62. [PMID: 34016257 DOI: 10.1016/j.jacc.2021.03.329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hess PL, Matlock DD, Al-Khatib SM. Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults. Clin Cardiol 2020;43:187-95. [PMID: 31867773 DOI: 10.1002/clc.23315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Imamura T, Kinugawa K, Sakata Y, Miyagawa S, Sawa Y, Yamazaki K, Ono M. Improved clinical course of autologous skeletal myoblast sheet (TCD-51073) transplantation when compared to a propensity score-matched cardiac resynchronization therapy population. J Artif Organs 2016;19:80-6. [PMID: 26267666 DOI: 10.1007/s10047-015-0862-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
7 AbdelWahab A, Sapp J. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate. Curr Cardiol Rep 2017;19:105. [PMID: 28900864 DOI: 10.1007/s11886-017-0924-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
8 Narayanan K, Reinier K, Teodorescu C, Uy-Evanado A, Aleong R, Chugh H, Nichols GA, Gunson K, London B, Jui J, Chugh SS. Left ventricular diameter and risk stratification for sudden cardiac death. J Am Heart Assoc 2014;3:e001193. [PMID: 25227407 DOI: 10.1161/JAHA.114.001193] [Cited by in Crossref: 36] [Cited by in F6Publishing: 15] [Article Influence: 5.1] [Reference Citation Analysis]
9 Yeung E, Krantz MJ, Schuller JL, Dale RA, Haigney MC. Ranolazine for the suppression of ventricular arrhythmia: a case series. Ann Noninvasive Electrocardiol 2014;19:345-50. [PMID: 24533675 DOI: 10.1111/anec.12137] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
10 Botto GL, Forleo GB, Capucci A, Solimene F, Vado A, Bertero G, Palmisano P, Pisanò E, Rapacciuolo A, Infusino T, Vicentini A, Viscusi M, Ferrari P, Talarico A, Russo G, Boriani G, Padeletti L, Lovecchio M, Valsecchi S, D'Onofrio A; ‘AIAC S-ICD Why Not’ Survey Investigators. The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not? Europace 2017;19:1826-32. [PMID: 28011803 DOI: 10.1093/europace/euw337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
11 Segreti L, Di Cori A, Zucchelli G, Soldati E, Coluccia G, Viani S, Paperini L, Bongiorni MG. A Questionable Indication For ICD Extraction After Successful VT Ablation. J Atr Fibrillation 2015;7:1172. [PMID: 27957158 DOI: 10.4022/jafib.1172] [Reference Citation Analysis]
12 Thomas G, Choi DY, Doppalapudi H, Richards M, Iwai S, Daoud EG, Houmsse M, Kanagasundram AN, Mainigi SK, Lubitz SA, Cheung JW. Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter-defibrillator systems: Results of the SENSE trial. J Cardiovasc Electrophysiol 2019;30:1994-2001. [PMID: 31328298 DOI: 10.1111/jce.14081] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
13 Kabutoya T, Mitsuhashi T, Shimizu A, Nitta T, Mitamura H, Kurita T, Abe H, Nakazato Y, Sumitomo N, Kadota K, Kimura K, Okumura K. Prognosis of Japanese Patients With Coronary Artery Disease Who Underwent Implantable Cardioverter Defibrillator Implantation - The JID-CAD Study. Circ Rep 2021;3:69-76. [PMID: 33693292 DOI: 10.1253/circrep.CR-20-0122] [Reference Citation Analysis]
14 Yamasaki H, Ando K, Ikeda T, Mitsuhashi T, Murohara T, Nishii N, Nogami A, Sakata Y, Shimizu W, Simon T, Beaudoint C, Kayser T, Kutyifa V, Aonuma K. Rationale and design of the HINODE study: Heart failure indication and sudden cardiac death prevention trial Japan. J Arrhythm 2021;37:1031-7. [PMID: 34386129 DOI: 10.1002/joa3.12577] [Reference Citation Analysis]
15 Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima K, Yu R, Vangala S, Tseng CH, Choi EK. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. Heart Rhythm. 2015;12:1997-2007. [PMID: 26031376 DOI: 10.1016/j.hrthm.2015.05.036] [Cited by in Crossref: 258] [Cited by in F6Publishing: 144] [Article Influence: 43.0] [Reference Citation Analysis]
16 Papageorgiou N, Falconer D, Ioannou A, Wongwarawipat T, Barra S, Tousoulis D, Lim WY, Khan FZ, Ahsan S, Muthumala A, Hunter RJ, Finlay M, Creta A, Rowland E, Lowe M, Segal OR, Schilling RJ, Lambiase PD, Chow AW, Providência R. Full blood count as potential predictor of outcomes in patients undergoing cardiac resynchronization therapy. Sci Rep 2019;9:13016. [PMID: 31506584 DOI: 10.1038/s41598-019-49659-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Nishii N, Noda T, Nitta T, Aizawa Y, Ohe T, Kurita T. Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy. Int J Cardiol Heart Vasc 2021;34:100779. [PMID: 33997254 DOI: 10.1016/j.ijcha.2021.100779] [Reference Citation Analysis]
18 Cakulev I, Mackall JA. One size fits all, or do we have to rethink optimal programming in implantable cardioverter-defibrillators implanted for secondary prevention? Heart Rhythm O2 2020;1:83-4. [PMID: 34115051 DOI: 10.1016/j.hroo.2020.05.001] [Reference Citation Analysis]
19 Mattsson G, Magnusson P. Long-term follow-up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality. Pacing Clin Electrophysiol 2020;43:245-53. [PMID: 31891421 DOI: 10.1111/pace.13869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
20 Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J Arrhythm 2016;32:1-28. [PMID: 26949427 DOI: 10.1016/j.joa.2015.12.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
21 Hofer D, Steffel J, Hürlimann D, Haegeli L, Lüscher TF, Duru F, Eriksson U, Krasniqi N. Long-term incidence of inappropriate shocks in patients with implantable cardioverter defibrillators in clinical practice-an underestimated complication? J Interv Card Electrophysiol 2017;50:219-26. [PMID: 29177981 DOI: 10.1007/s10840-017-0297-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Demarchi A, Cornara S, Sanzo A, Savastano S, Petracci B, Vicentini A, Pontillo L, Baldi E, Frigerio L, Astuti M, Leonardi S, Ghio S, Oltrona Visconti L, Rordorf R. Incidence of Ventricular Arrhythmias and 1-Year Predictors of Mortality in Patients Treated With Implantable Cardioverter-Defibrillator Undergoing Generator Replacement. J Am Heart Assoc 2021;10:e018090. [PMID: 33522246 DOI: 10.1161/JAHA.120.018090] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Cadrin-Tourigny J, Bosman LP, Wang W, Tadros R, Bhonsale A, Bourfiss M, Lie ØH, Saguner AM, Svensson A, Andorin A, Tichnell C, Murray B, Zeppenfeld K, van den Berg MP, Asselbergs FW, Wilde AAM, Krahn AD, Talajic M, Rivard L, Chelko S, Zimmerman SL, Kamel IR, Crosson JE, Judge DP, Yap SC, Van der Heijden JF, Tandri H, Jongbloed JDH, van Tintelen JP, Platonov PG, Duru F, Haugaa KH, Khairy P, Hauer RNW, Calkins H, Te Riele ASJM, James CA. Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration. Circ Arrhythm Electrophysiol 2021;14:e008509. [PMID: 33296238 DOI: 10.1161/CIRCEP.120.008509] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
24 Lamichhane M, Gardiner JC, Bianco NR, Szymkiewicz SJ, Thakur RK. National experience with long-term use of the wearable cardioverter defibrillator in patients with cardiomyopathy. J Interv Card Electrophysiol. 2017;48:11-19. [PMID: 27752809 DOI: 10.1007/s10840-016-0194-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
25 Fleeman BE, Aleong RG. Optimal Strategies to Reduce Inappropriate Implantable Cardioverter-defibrillator Shocks. J Innov Card Rhythm Manag 2019;10:3623-32. [PMID: 32477727 DOI: 10.19102/icrm.2019.100403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Mustafa U, Dherange P, Reddy R, DeVillier J, Chong J, Ihsan A, Jones R, Duddyala N, Reddy P, Dominic P. Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018;7:e010156. [PMID: 30554547 DOI: 10.1161/JAHA.118.010156] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
27 Wäßnig NK, Günther M, Quick S, Pfluecke C, Rottstädt F, Szymkiewicz SJ, Ringquist S, Strasser RH, Speiser U. Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death. Circulation 2016;134:635-43. [PMID: 27458236 DOI: 10.1161/CIRCULATIONAHA.115.019124] [Cited by in Crossref: 58] [Cited by in F6Publishing: 18] [Article Influence: 11.6] [Reference Citation Analysis]
28 Malhotra S, Fernandez SF, Fallavollita JA, Canty JM Jr. Prognostic Significance of Imaging Myocardial Sympathetic Innervation. Curr Cardiol Rep 2015;17:62. [PMID: 26087899 DOI: 10.1007/s11886-015-0613-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
29 Radinovic A, Baratto F, Della Bella P. Optimal Timing of VT Ablation for Patients with ICD Therapies. Curr Cardiol Rep 2020;22:91. [PMID: 32648057 DOI: 10.1007/s11886-020-01345-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Nazer B, Dale Z, Carrassa G, Reza N, Ustunkaya T, Papoutsidakis N, Gray A, Howell SJ, Elman MR, Pieragnoli P, Ricciardi G, Jacoby D, Frankel DS, Owens A, Olivotto I, Heitner SB. Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study. Heart Rhythm 2020;17:1107-14. [PMID: 32084597 DOI: 10.1016/j.hrthm.2020.02.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
31 Motloch LJ, Ishikawa K, Xie C, Hu J, Aguero J, Fish KM, Hajjar RJ, Akar FG. Increased afterload following myocardial infarction promotes conduction-dependent arrhythmias that are unmasked by hypokalemia. JACC Basic Transl Sci 2017;2:258-69. [PMID: 28798965 DOI: 10.1016/j.jacbts.2017.02.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
32 Brewster J, Sexton T, Dhaliwal G, Charnigo R, Morales G, Parrott K, Darrat Y, Gurley J, Smyth S, Elayi CS. Acute Effects of Implantable Cardioverter-Defibrillator Shocks on Biomarkers of Myocardial Injury, Apoptosis, Heart Failure, and Systemic Inflammation. Pacing Clin Electrophysiol 2017;40:344-52. [PMID: 28156007 DOI: 10.1111/pace.13037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Goldstein SA, Ward CC, Al-Khatib SM. The Use of Implantable Cardioverter-defibrillators in the Prevention of Sudden Cardiac Death: A Focus on Congenital Heart Disease and Inherited Arrhythmia Syndromes. J Innov Card Rhythm Manag 2018;9:2996-3005. [PMID: 32494470 DOI: 10.19102/icrm.2018.090103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Yazaki K, Suzuki A, Shiga T, Minami Y, Arai K, Ashihara K, Shoda M, Hagiwara N. Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention. BMC Cardiovasc Disord 2021;21:106. [PMID: 33607967 DOI: 10.1186/s12872-021-01910-0] [Reference Citation Analysis]
35 Lee S, Li KHC, Zhou J, Leung KSK, Lai RWC, Li G, Liu T, Letsas KP, Mok NS, Zhang Q, Tse G. Outcomes in Brugada Syndrome Patients With Implantable Cardioverter-Defibrillators: Insights From the SGLT2 Registry. Front Physiol 2020;11:204. [PMID: 32210841 DOI: 10.3389/fphys.2020.00204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
36 Zeitler EP, Al-Khatib SM, Friedman DJ, Han JY, Poole JE, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD. Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II. J Cardiovasc Electrophysiol 2017;28:1345-51. [PMID: 28744959 DOI: 10.1111/jce.13307] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
37 Muser D, Santangeli P, Liang JJ. Management of ventricular tachycardia storm in patients with structural heart disease. World J Cardiol 2017;9:521-30. [PMID: 28706587 DOI: 10.4330/wjc.v9.i6.521] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
38 Merchant FM, Zheng H, Bigger T, Steinman R, Ikeda T, Pedretti RF, Salerno-Uriarte JA, Klersy C, Chan PS, Bartone C. A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification. Am Heart J. 2013;166:744-752. [PMID: 24093856 DOI: 10.1016/j.ahj.2013.06.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
39 Clerkin KJ, Topkara VK, Demmer RT, Dizon JM, Yuzefpolskaya M, Fried JA, Mai X, Mancini DM, Takeda K, Takayama H, Naka Y, Colombo PC, Garan AR. Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry. JACC Heart Fail 2017;5:916-26. [PMID: 29191299 DOI: 10.1016/j.jchf.2017.08.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 6.3] [Reference Citation Analysis]
40 Borne RT, Katz D, Betz J, Peterson PN, Masoudi FA. Implantable Cardioverter-Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review. J Am Heart Assoc 2017;6:e005515. [PMID: 28258050 DOI: 10.1161/JAHA.117.005515] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
41 Corrado D, Wichter T, Link MS, Hauer RN, Marchlinski FE, Anastasakis A, Bauce B, Basso C, Brunckhorst C, Tsatsopoulou A, Tandri H, Paul M, Schmied C, Pelliccia A, Duru F, Protonotarios N, Estes NM 3rd, McKenna WJ, Thiene G, Marcus FI, Calkins H. Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement. Circulation 2015;132:441-53. [PMID: 26216213 DOI: 10.1161/CIRCULATIONAHA.115.017944] [Cited by in Crossref: 172] [Cited by in F6Publishing: 39] [Article Influence: 28.7] [Reference Citation Analysis]
42 Lampert R. Behavioral influences on cardiac arrhythmias. Trends Cardiovasc Med 2016;26:68-77. [PMID: 25983071 DOI: 10.1016/j.tcm.2015.04.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
43 Baalman SWE, Quast ABE, Brouwer TF, Knops RE. An Overview of Clinical Outcomes in Transvenous and Subcutaneous ICD Patients. Curr Cardiol Rep 2018;20:72. [PMID: 29992422 DOI: 10.1007/s11886-018-1021-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
44 Malhotra S, Canty JM Jr. Structural and Physiological Imaging to Predict the Risk of Lethal Ventricular Arrhythmias and Sudden Death. JACC Cardiovasc Imaging 2019;12:2049-64. [PMID: 31601379 DOI: 10.1016/j.jcmg.2019.05.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
45 Thøgersen AM, Larsen JM, Johansen JB, Abedin M, Swerdlow CD. Failure to Treat Life-Threatening Ventricular Tachyarrhythmias in Contemporary Implantable Cardioverter-Defibrillators: Implications for Strategic Programming. Circ Arrhythm Electrophysiol 2017;10:e005305. [PMID: 28916511 DOI: 10.1161/CIRCEP.117.005305] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
46 Perrin T, Boveda S, Defaye P, Rosier A, Sadoul N, Bordachar P, Klug D, Ritter P, Belhameche M, Babuty D, Mansourati J, Lazarus A, Deharo JC. Role of medical reaction in management of inappropriate ventricular arrhythmia diagnosis: the inappropriate Therapy and HOme monitoRiNg (THORN) registry. Europace 2019;21:607-15. [PMID: 30605510 DOI: 10.1093/europace/euy284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Auricchio A, Hudnall JH, Schloss EJ, Sterns LD, Kurita T, Meijer A, Fagan DH, Rogers T. Inappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis. Europace 2017;19:1973-80. [PMID: 28340005 DOI: 10.1093/europace/euw415] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
48 Frommeyer G, Zumhagen S, Dechering DG, Larbig R, Bettin M, Löher A, Köbe J, Reinke F, Eckardt L. Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter-Defibrillator Systems-A Simple Issue? J Am Heart Assoc 2016;5:e003181. [PMID: 27068637 DOI: 10.1161/JAHA.115.003181] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
49 Gatzoulis KA, Tsiachris D, Arsenos P, Antoniou CK, Dilaveris P, Sideris S, Kanoupakis E, Simantirakis E, Korantzopoulos P, Goudevenos I, Flevari P, Iliodromitis E, Sideris A, Vassilikos V, Fragakis N, Trachanas K, Vernardos M, Konstantinou I, Tsimos K, Xenogiannis I, Vlachos K, Saplaouras A, Triantafyllou K, Kallikazaros I, Tousoulis D. Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study. Eur Heart J 2019;40:2940-9. [PMID: 31049557 DOI: 10.1093/eurheartj/ehz260] [Cited by in Crossref: 44] [Cited by in F6Publishing: 16] [Article Influence: 44.0] [Reference Citation Analysis]
50 Romero J, Mejia-Lopez E, Manrique C, Lucariello R. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D): A Systematic Literature Review. Clin Med Insights Cardiol 2013;7:97-114. [PMID: 23761986 DOI: 10.4137/CMC.S10940] [Cited by in Crossref: 59] [Cited by in F6Publishing: 16] [Article Influence: 7.4] [Reference Citation Analysis]
51 Proietti R, Joza J, Essebag V. Therapy for ventricular arrhythmias in structural heart disease: a multifaceted challenge. J Physiol 2016;594:2431-43. [PMID: 26621333 DOI: 10.1113/JP270534] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
52 Selvanayagam JB, Hartshorne T, Billot L, Grover S, Hillis GS, Jung W, Krum H, Prasad S, McGavigan AD. Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial. Ann Noninvasive Electrocardiol 2017;22. [PMID: 28117536 DOI: 10.1111/anec.12420] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
53 Greenlee RT, Go AS, Peterson PN, Cassidy-Bushrow AE, Gaber C, Garcia-Montilla R, Glenn KA, Gupta N, Gurwitz JH, Hammill SC, Hayes JJ, Kadish A, Magid DJ, McManus DD, Multerer D, Powers JD, Reifler LM, Reynolds K, Schuger C, Sharma PP, Smith DH, Suits M, Sung SH, Varosy PD, Vidaillet HJ, Masoudi FA. Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network. J Am Heart Assoc 2018;7:e008292. [PMID: 29581222 DOI: 10.1161/JAHA.117.008292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
54 Lampert R. Mental Stress and Ventricular Arrhythmias. Curr Cardiol Rep 2016;18:118. [PMID: 27796855 DOI: 10.1007/s11886-016-0798-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
55 Wang L, Fahimian B, Soltys SG, Zei P, Lo A, Gardner EA, Maguire PJ, Loo BW Jr. Stereotactic Arrhythmia Radioablation (STAR) of Ventricular Tachycardia: A Treatment Planning Study. Cureus. 2016;8:e694. [PMID: 27570715 DOI: 10.7759/cureus.694] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
56 Dougherty CM, Glenny RW, Burr RL, Flo GL, Kudenchuk PJ. Prospective randomized trial of moderately strenuous aerobic exercise after an implantable cardioverter defibrillator. Circulation 2015;131:1835-42. [PMID: 25792557 DOI: 10.1161/CIRCULATIONAHA.114.014444] [Cited by in Crossref: 35] [Cited by in F6Publishing: 9] [Article Influence: 5.8] [Reference Citation Analysis]
57 Corrado D, Wichter T, Link MS, Hauer R, Marchlinski F, Anastasakis A, Bauce B, Basso C, Brunckhorst C, Tsatsopoulou A, Tandri H, Paul M, Schmied C, Pelliccia A, Duru F, Protonotarios N, Estes NA 3rd, McKenna WJ, Thiene G, Marcus FI, Calkins H. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. Eur Heart J. 2015;36:3227-3237. [PMID: 26216920 DOI: 10.1093/eurheartj/ehv162] [Cited by in Crossref: 16] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
58 Bodin A, Labas V, Bisson A, Teixeira-Gomes AP, Blasco H, Tomas D, Combes-Soia L, Marcelo P, Miquelestorena-Standley E, Baron C, Angoulvant D, Babuty D, Clementy N. Acute pathophysiological myocardial changes following intra-cardiac electrical shocks using a proteomic approach in a sheep model. Sci Rep 2020;10:20252. [PMID: 33219330 DOI: 10.1038/s41598-020-77346-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Friedman DJ, Al-Khatib SM. Measuring quality in electrophysiology. J Interv Card Electrophysiol 2016;47:5-10. [PMID: 26936264 DOI: 10.1007/s10840-016-0118-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
60 Horlbeck FW, Schwab JO. Programming implantable cardioverter/defibrillators and outcomes. F1000Prime Rep 2015;7:10. [PMID: 25705393 DOI: 10.12703/P7-10] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
61 Merchant FM, Sayadi O, Puppala D, Moazzami K, Heller V, Armoundas AA. A translational approach to probe the proarrhythmic potential of cardiac alternans: a reversible overture to arrhythmogenesis? Am J Physiol Heart Circ Physiol 2014;306:H465-74. [PMID: 24322612 DOI: 10.1152/ajpheart.00639.2013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
62 Tao S, Ashikaga H, Ciuffo LA, Yoneyama K, Lima JAC, Frank TF, Weiss RG, Tomaselli GF, Wu KC. Impaired left atrial function predicts inappropriate shocks in primary prevention implantable cardioverter-defibrillator candidates. J Cardiovasc Electrophysiol 2017;28:796-805. [PMID: 28429529 DOI: 10.1111/jce.13234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
63 Arenal A, Proclemer A, Kloppe A, Lunati M, Martìnez Ferrer JB, Hersi A, Gulaj M, Wijffels MC, Santi E, Manotta L, Mangoni L, Gasparini M. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial. Europace 2016;18:1719-25. [PMID: 27485577 DOI: 10.1093/europace/euw032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
64 Friedman DJ, Fudim M, Overton R, Shaw LK, Patel D, Pokorney SD, Velazquez EJ, Al-Khatib SM. The relationship between baseline and follow-up left ventricular ejection fraction with adverse events among primary prevention ICD patients. Am Heart J 2018;201:17-24. [PMID: 29910051 DOI: 10.1016/j.ahj.2018.03.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Duncker D, Veltmann C. Role of the Wearable Defibrillator in Newly Diagnosed Heart Failure. Curr Heart Fail Rep 2018;15:368-75. [PMID: 30353399 DOI: 10.1007/s11897-018-0415-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
66 Peterson PN, Varosy PD, Heidenreich PA, Wang Y, Dewland TA, Curtis JP, Go AS, Greenlee RT, Magid DJ, Normand SL, Masoudi FA. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA 2013;309:2025-34. [PMID: 23677314 DOI: 10.1001/jama.2013.4982] [Cited by in Crossref: 78] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
67 Steinberg JS, Varma N, Cygankiewicz I, Aziz P, Balsam P, Baranchuk A, Cantillon DJ, Dilaveris P, Dubner SJ, El-Sherif N, Krol J, Kurpesa M, La Rovere MT, Lobodzinski SS, Locati ET, Mittal S, Olshansky B, Piotrowicz E, Saxon L, Stone PH, Tereshchenko L, Turakhia MP, Turitto G, Wimmer NJ, Verrier RL, Zareba W, Piotrowicz R. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Ann Noninvasive Electrocardiol 2017;22. [PMID: 28480632 DOI: 10.1111/anec.12447] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 9.7] [Reference Citation Analysis]
68 Ndounga Diakou LA, Trinquart L, Hróbjartsson A, Barnes C, Yavchitz A, Ravaud P, Boutron I. Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates. Cochrane Database Syst Rev 2016;3:MR000043. [PMID: 26961577 DOI: 10.1002/14651858.MR000043.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
69 Reeder HT, Shen C, Buxton AE, Haneuse SJ, Kramer DB. Joint Shock/Death Risk Prediction Model for Patients Considering Implantable Cardioverter-Defibrillators. Circ Cardiovasc Qual Outcomes 2019;12:e005675. [PMID: 31412732 DOI: 10.1161/CIRCOUTCOMES.119.005675] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
70 Tang PT, Do DH, Li A, Boyle NG. Team Management of the Ventricular Tachycardia Patient. Arrhythm Electrophysiol Rev 2018;7:238-46. [PMID: 30588311 DOI: 10.15420/aer.2018.37.2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
71 Corden B, Jarman J, Whiffin N, Tayal U, Buchan R, Sehmi J, Harper A, Midwinter W, Lascelles K, Markides V, Mason M, Baksi J, Pantazis A, Pennell DJ, Barton PJ, Prasad SK, Wong T, Cook SA, Ware JS. Association of Titin-Truncating Genetic Variants With Life-threatening Cardiac Arrhythmias in Patients With Dilated Cardiomyopathy and Implanted Defibrillators. JAMA Netw Open 2019;2:e196520. [PMID: 31251381 DOI: 10.1001/jamanetworkopen.2019.6520] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
72 Yokoshiki H, Shimizu A, Mitsuhashi T, Furushima H, Sekiguchi Y, Manaka T, Nishii N, Ueyama T, Morita N, Okamura H, Nitta T, Hirao K, Okumura K; Members of the Implantable Cardioverter‐Defibrillator (ICD) Committee of the Japanese Heart Rhythm Society. Prognostic significance of nonsustained ventricular tachycardia in patients receiving cardiac resynchronization therapy for primary prevention: Analysis of the Japan cardiac device treatment registry database. J Arrhythm 2018;34:139-47. [PMID: 29657589 DOI: 10.1002/joa3.12023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
73 Watanabe E, Abe H, Watanabe S. Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers. J Arrhythm 2017;33:594-601. [PMID: 29255507 DOI: 10.1016/j.joa.2017.02.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
74 Hasin T, Davarashvili I, Michowitz Y, Farkash R, Presman H, Glikson M, Rav-Acha M. Association of Guideline-Based Medical Therapy with Malignant Arrhythmias and Mortality among Heart Failure Patients Implanted with Cardioverter Defibrillator (ICD) or Cardiac Resynchronization-Defibrillator Device (CRTD). J Clin Med 2021;10:1753. [PMID: 33920719 DOI: 10.3390/jcm10081753] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Ponamgi SP, DeSimone CV, Ackerman MJ. Athletes with Implantable Cardioverter Defibrillators. Clin Sports Med 2015;34:473-87. [PMID: 26100423 DOI: 10.1016/j.csm.2015.03.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Muser D, Liang JJ, Santangeli P. Electrical Storm in Patients with Implantable Cardioverter-defibrillators: A Practical Overview. J Innov Card Rhythm Manag 2017;8:2853-61. [PMID: 32477756 DOI: 10.19102/icrm.2017.081002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
77 Zabel M, Willems R, Lubinski A, Bauer A, Brugada J, Conen D, Flevari P, Hasenfuß G, Svetlosak M, Huikuri HV, Malik M, Pavlović N, Schmidt G, Sritharan R, Schlögl S, Szavits-Nossan J, Traykov V, Tuinenburg AE, Willich SN, Harden M, Friede T, Svendsen JH, Sticherling C, Merkely B; EU-CERT-ICD Study Investigators. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study. Eur Heart J 2020;41:3437-47. [PMID: 32372094 DOI: 10.1093/eurheartj/ehaa226] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 21.0] [Reference Citation Analysis]
78 Gold MR, Lambiase PD, El-Chami MF, Knops RE, Aasbo JD, Bongiorni MG, Russo AM, Deharo JC, Burke MC, Dinerman J, Barr CS, Shaik N, Carter N, Stoltz T, Stein KM, Brisben AJ, Boersma LVA; UNTOUCHED Investigators*. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial. Circulation 2021;143:7-17. [PMID: 33073614 DOI: 10.1161/CIRCULATIONAHA.120.048728] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 14.0] [Reference Citation Analysis]
79 Magnusson P, Mörner S, Gadler F, Karlsson J. Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators. Health Qual Life Outcomes 2016;14:62. [PMID: 27079917 DOI: 10.1186/s12955-016-0467-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
80 Ooi SL, He HG, Dong Y, Wang W. Perceptions and experiences of patients living with implantable cardioverter defibrillators: a systematic review and meta-synthesis. Health Qual Life Outcomes 2016;14:160. [PMID: 27855698 DOI: 10.1186/s12955-016-0561-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
81 Zabel M, Sticherling C, Willems R, Lubinski A, Bauer A, Bergau L, Braunschweig F, Brugada J, Brusich S, Conen D, Cygankiewicz I, Flevari P, Taborsky M, Hansen J, Hasenfuß G, Hatala R, Huikuri HV, Iovev S, Kääb S, Kaliska G, Kasprzak JD, Lüthje L, Malik M, Novotny T, Pavlović N, Schmidt G, Shalganov T, Sritharan R, Schlögl S, Szavits Nossan J, Traykov V, Tuinenburg AE, Velchev V, Vos MA, Willich SN, Friede T, Svendsen JH, Merkely B; EU-CERT-ICD Study Investigators. Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation. ESC Heart Fail 2019;6:182-93. [PMID: 30299600 DOI: 10.1002/ehf2.12367] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
82 Narayan SM, Wang PJ, Daubert JP. New Concepts in Sudden Cardiac Arrest to Address an Intractable Epidemic: JACC State-of-the-Art Review. J Am Coll Cardiol 2019;73:70-88. [PMID: 30621954 DOI: 10.1016/j.jacc.2018.09.083] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
83 Chery G, Kamp N, Kosinski AS, Schmidler GS, Lopes RD, Patel M, Al-Khatib SM. Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: A systematic review. Am Heart J 2020;229:52-60. [PMID: 32916608 DOI: 10.1016/j.ahj.2020.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Erath JW, Vamos M, Sirat AS, Hohnloser SH. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients. Clin Res Cardiol 2017;106:300-6. [PMID: 27888304 DOI: 10.1007/s00392-016-1054-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
85 Mijic D, Lemke B, Bogossian H. [Fitness to drive in patients with cardiovascular implantable electronic devices]. Herzschrittmacherther Elektrophysiol 2019;30:150-5. [PMID: 31073643 DOI: 10.1007/s00399-019-0626-y] [Reference Citation Analysis]
86 Bracke FA, van Gelder BM. Managing patients with advisory defibrillator leads: what can we learn from published data? Neth Heart J 2015;23:199-204. [PMID: 25884090 DOI: 10.1007/s12471-015-0669-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
87 Yokoshiki H, Shimizu A, Mitsuhashi T, Ishibashi K, Kabutoya T, Yoshiga Y, Kohno R, Abe H, Nogami A; Members of the Implantable Cardioverter‐Defibrillator (ICD) Committee of the Japanese Heart Rhythm Society. Current status and role of programmed ventricular stimulation in patients without sustained ventricular arrhythmias and reduced ejection fraction: Analysis of the Japan cardiac device treatment registry database. J Arrhythm 2021;37:148-56. [PMID: 33664897 DOI: 10.1002/joa3.12468] [Reference Citation Analysis]
88 Merchant FM, Jones P, Wehrenberg S, Lloyd MS, Saxon LA. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life. J Am Heart Assoc 2014;3:e001289. [PMID: 25385346 DOI: 10.1161/JAHA.114.001289] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
89 Park KH, Lee CH, Jung BC, Cho Y, Bae MH, Kim YN, Park HS, Han S, Lee YS, Hyun DW, Kim J, Kim DK, Cha TJ, Shin DG. Effectiveness of Implantable Cardioverter-Defibrillator Therapy for Heart Failure Patients according to Ischemic or Non-Ischemic Etiology in Korea. Korean Circ J 2017;47:72-81. [PMID: 28154594 DOI: 10.4070/kcj.2016.0242] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
90 Niehues P, Frommeyer G, Reinke F, Eckardt L. [Subcutaneous implantable cardioverter-defibrillator : Current status and perspectives]. Herzschrittmacherther Elektrophysiol 2018;29:349-54. [PMID: 30306303 DOI: 10.1007/s00399-018-0593-8] [Reference Citation Analysis]
91 Vaseghi M, Barwad P, Malavassi Corrales FJ, Tandri H, Mathuria N, Shah R, Sorg JM, Gima J, Mandal K, Sàenz Morales LC, Lokhandwala Y, Shivkumar K. Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias. J Am Coll Cardiol 2017;69:3070-80. [PMID: 28641796 DOI: 10.1016/j.jacc.2017.04.035] [Cited by in Crossref: 151] [Cited by in F6Publishing: 100] [Article Influence: 37.8] [Reference Citation Analysis]
92 Barraud J, Cautela J, Orabona M, Pinto J, Missenard O, Laine M, Thuny F, Paganelli F, Bonello L, Peyrol M. Wearable cardioverter defibrillator: Bridge or alternative to implantation? World J Cardiol 2017;9:531-8. [PMID: 28706588 DOI: 10.4330/wjc.v9.i6.531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
93 Ramírez J, van Duijvenboden S, Young WJ, Orini M, Jones AR, Lambiase PD, Munroe PB, Tinker A. Analysing electrocardiographic traits and predicting cardiac risk in UK biobank. JRSM Cardiovasc Dis 2021;10:20480040211023664. [PMID: 34211707 DOI: 10.1177/20480040211023664] [Reference Citation Analysis]
94 Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB, Hood M, Pedersen S, Kääb S, Murgatroyd F, Reeve HL, Carter N, Boersma L; EFFORTLESS Investigators. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. Eur Heart J 2014;35:1657-65. [PMID: 24670710 DOI: 10.1093/eurheartj/ehu112] [Cited by in Crossref: 326] [Cited by in F6Publishing: 178] [Article Influence: 46.6] [Reference Citation Analysis]
95 Clementy N, Bodin A, Bisson A, Teixeira-Gomes AP, Roger S, Angoulvant D, Labas V, Babuty D. The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy. Int J Mol Sci 2021;22:5003. [PMID: 34066832 DOI: 10.3390/ijms22095003] [Reference Citation Analysis]
96 Zhang Y, Kennedy R, Blasco-Colmenares E, Butcher B, Norgard S, Eldadah Z, Dickfeld T, Ellenbogen KA, Marine JE, Guallar E, Tomaselli GF, Cheng A. Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD). Heart Rhythm 2014;11:1377-83. [PMID: 24793459 DOI: 10.1016/j.hrthm.2014.04.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
97 Aktas MK, Bennett AL, Younis A, Kutyifa V, Polonsky B, McNitt S, Zareba W, Rosero S, Goldenberg I. Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Heart Rhythm O2 2020;1:77-82. [PMID: 34113861 DOI: 10.1016/j.hroo.2020.04.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Schukro C, Santer D, Prenner G, Stühlinger M, Martinek M, Teubl A, Moertl D, Schwarz S, Nürnberg M, Fiedler L, Hatala R, Khazen C. State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy. Clin Cardiol 2020;43:1084-92. [PMID: 32794309 DOI: 10.1002/clc.23432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
99 Correale M, Monaco I, Tricarico L, Bottigliero D, Sicuranza M, Del Forno B, Godeas G, Teri A, Maiorano A, Perulli R, Centola A, De Bonis M, Di Biase M, Brunetti ND. Advanced heart failure: non-pharmacological approach. Heart Fail Rev 2019;24:779-91. [PMID: 30972521 DOI: 10.1007/s10741-019-09786-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
100 Aleong RG, Mulvahill MJ, Halder I, Carlson NE, Singh M, Bloom HL, Dudley SC, Ellinor PT, Shalaby A, Weiss R, Gutmann R, Sauer WH, Narayanan K, Chugh SS, Saba S, London B. Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic Function. J Am Heart Assoc 2015;4:e001566. [PMID: 26231842 DOI: 10.1161/JAHA.114.001566] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
101 De Maria E, Giacopelli D, Borghi A, Modonesi L, Cappelli S. Antitachycardia pacing programming in implantable cardioverter defibrillator: A systematic review. World J Cardiol 2017;9:429-36. [PMID: 28603590 DOI: 10.4330/wjc.v9.i5.429] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
102 Burger AL, Schmidinger H, Ristl R, Pezawas T. Sex difference in inappropriate therapy and survival among 1471 implantable cardioverter-defibrillator recipients. J Cardiovasc Electrophysiol 2019;30:1620-5. [PMID: 31165550 DOI: 10.1111/jce.14003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
103 Cheema MA, Almas T, Ullah W, Haas D. RV lead placement - A forgotten cause of right heart failure. Ann Med Surg (Lond) 2021;67:102461. [PMID: 34158932 DOI: 10.1016/j.amsu.2021.102461] [Reference Citation Analysis]
104 Madhavan M, Waks JW, Friedman PA, Kramer DB, Buxton AE, Noseworthy PA, Mehta RA, Hodge DO, Higgins AY, Webster TL, Witt CM, Cha YM, Gersh BJ. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death. Circ Arrhythm Electrophysiol 2016;9:e003283. [PMID: 26921377 DOI: 10.1161/CIRCEP.115.003283] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 6.8] [Reference Citation Analysis]
105 Chubb H, Rosenthal E. Implantable cardioverter-defibrillators in congenital heart disease. Herzschrittmacherther Elektrophysiol 2016;27:95-103. [PMID: 27250725 DOI: 10.1007/s00399-016-0437-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
106 Briongos-Figuero S, Sánchez A, Pérez ML, Martínez-Ferrer JB, García E, Viñolas X, Arenal Á, Alzueta J, Basterra N, Rodríguez A, Lozano I, Muñoz-Aguilera R. Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices. J Interv Card Electrophysiol 2019;54:267-75. [PMID: 30523511 DOI: 10.1007/s10840-018-0494-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
107 Pokorney SD, Friedman DJ, Calkins H, Callans DJ, Daoud EG, Della-Bella P, Jackson KP, Shivkumar K, Saba S, Sapp J, Stevenson WG, Al-Khatib SM. Catheter ablation of ventricular tachycardia: Lessons learned from past clinical trials and implications for future clinical trials. Heart Rhythm 2016;13:1748-54. [PMID: 27050910 DOI: 10.1016/j.hrthm.2016.04.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 3.2] [Reference Citation Analysis]
108 Sroubek J, Probst V, Mazzanti A, Delise P, Hevia JC, Ohkubo K, Zorzi A, Champagne J, Kostopoulou A, Yin X. Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis. Circulation. 2016;133:622-630. [PMID: 26797467 DOI: 10.1161/circulationaha.115.017885] [Cited by in Crossref: 123] [Cited by in F6Publishing: 30] [Article Influence: 24.6] [Reference Citation Analysis]
109 MacIntyre CJ, Sapp JL, Abdelwahab A, Al-Harbi M, Doucette S, Gray C, Gardner MJ, Parkash R. The Effect of Shock Burden on Heart Failure and Mortality. CJC Open 2019;1:161-7. [PMID: 32159102 DOI: 10.1016/j.cjco.2019.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
110 Bogossian H, Panteloglou D, Karosiene Z, Macher-Heidrich S, Adomeit HJ, Lemke B, Israel CW. [Perioprocedural mortality after ICD implantation]. Herz 2021. [PMID: 33860805 DOI: 10.1007/s00059-021-05033-2] [Reference Citation Analysis]
111 Peterson PN, Greenlee RT, Go AS, Magid DJ, Cassidy-Bushrow A, Garcia-Montilla R, Glenn KA, Gurwitz JH, Hammill SC, Hayes J, Kadish A, Reynolds K, Sharma P, Smith DH, Varosy PD, Vidaillet H, Zeng CX, Normand ST, Masoudi FA. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. J Am Heart Assoc 2017;6:e006937. [PMID: 29122811 DOI: 10.1161/JAHA.117.006937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
112 Sticherling C, Arendacka B, Svendsen JH, Wijers S, Friede T, Stockinger J, Dommasch M, Merkely B, Willems R, Lubinski A, Scharfe M, Braunschweig F, Svetlosak M, Zürn CS, Huikuri H, Flevari P, Lund-Andersen C, Schaer BA, Tuinenburg AE, Bergau L, Schmidt G, Szeplaki G, Vandenberk B, Kowalczyk E, Eick C, Juntilla J, Conen D, Zabel M; EU-CERT-ICD Investigators. Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries. Europace 2018;20:963-70. [PMID: 29016784 DOI: 10.1093/europace/eux176] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
113 Chen J, Johnson G, Hellkamp AS, Anderson J, Mark DB, Lee KL, Bardy GH, Poole JE. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2013;61:2161-8. [PMID: 23541974 DOI: 10.1016/j.jacc.2013.02.046] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
114 Willy K, Bettin M, Reinke F, Bögeholz N, Ellermann C, Rath B, Leitz P, Köbe J, Eckardt L, Frommeyer G. Feasibility of entirely subcutaneous ICD™ systems in patients with coronary artery disease. Clin Res Cardiol 2019;108:1234-9. [PMID: 30903274 DOI: 10.1007/s00392-019-01455-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
115 Sennhauser S, Anand R, Kusumoto F, Goldschlager N. Heart Rhythm Society: expert consensus statements-part 1. Clin Cardiol 2017;40:177-85. [PMID: 28273360 DOI: 10.1002/clc.22666] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
116 Krokhaleva Y, Vaseghi M. Update on prevention and treatment of sudden cardiac arrest. Trends Cardiovasc Med 2019;29:394-400. [PMID: 30449537 DOI: 10.1016/j.tcm.2018.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]